nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—Gefitinib—EGFR—cervical cancer	0.026	1	CrCbGaD
Iloperidone—SIGMAR1—uterine cervix—cervical cancer	0.0121	0.0284	CbGeAlD
Iloperidone—SIGMAR1—decidua—cervical cancer	0.0115	0.0271	CbGeAlD
Iloperidone—SIGMAR1—endometrium—cervical cancer	0.0109	0.0257	CbGeAlD
Iloperidone—SIGMAR1—mammalian vulva—cervical cancer	0.0106	0.0249	CbGeAlD
Iloperidone—HTR7—epithelium—cervical cancer	0.0104	0.0245	CbGeAlD
Iloperidone—HTR1A—renal system—cervical cancer	0.0101	0.0238	CbGeAlD
Iloperidone—SIGMAR1—uterus—cervical cancer	0.0101	0.0237	CbGeAlD
Iloperidone—ADRA1A—epithelium—cervical cancer	0.01	0.0236	CbGeAlD
Iloperidone—HTR1D—female reproductive system—cervical cancer	0.00972	0.0229	CbGeAlD
Iloperidone—HTR7—renal system—cervical cancer	0.00966	0.0227	CbGeAlD
Iloperidone—HTR2C—female reproductive system—cervical cancer	0.00962	0.0226	CbGeAlD
Iloperidone—ADRA2C—uterine cervix—cervical cancer	0.00949	0.0223	CbGeAlD
Iloperidone—ADRA1A—renal system—cervical cancer	0.00932	0.0219	CbGeAlD
Iloperidone—ADRA2C—decidua—cervical cancer	0.00905	0.0213	CbGeAlD
Iloperidone—ADRA2C—renal system—cervical cancer	0.00888	0.0209	CbGeAlD
Iloperidone—ADRA2C—endometrium—cervical cancer	0.00859	0.0202	CbGeAlD
Iloperidone—ADRA2C—mammalian vulva—cervical cancer	0.00831	0.0195	CbGeAlD
Iloperidone—SIGMAR1—female gonad—cervical cancer	0.00824	0.0194	CbGeAlD
Iloperidone—SIGMAR1—vagina—cervical cancer	0.00819	0.0193	CbGeAlD
Iloperidone—CYP3A5—uterine cervix—cervical cancer	0.00795	0.0187	CbGeAlD
Iloperidone—ADRA2C—uterus—cervical cancer	0.00791	0.0186	CbGeAlD
Iloperidone—HRH1—epithelium—cervical cancer	0.00778	0.0183	CbGeAlD
Iloperidone—HTR7—female reproductive system—cervical cancer	0.00774	0.0182	CbGeAlD
Iloperidone—HRH1—uterine cervix—cervical cancer	0.00771	0.0181	CbGeAlD
Iloperidone—CYP1A2—renal system—cervical cancer	0.00771	0.0181	CbGeAlD
Iloperidone—ADRA2A—uterine cervix—cervical cancer	0.00758	0.0178	CbGeAlD
Iloperidone—CYP3A5—renal system—cervical cancer	0.00743	0.0175	CbGeAlD
Iloperidone—HRH1—decidua—cervical cancer	0.00735	0.0173	CbGeAlD
Iloperidone—ADRA2A—decidua—cervical cancer	0.00722	0.017	CbGeAlD
Iloperidone—HRH1—endometrium—cervical cancer	0.00698	0.0164	CbGeAlD
Iloperidone—CYP2E1—renal system—cervical cancer	0.00693	0.0163	CbGeAlD
Iloperidone—ADRA2A—endometrium—cervical cancer	0.00685	0.0161	CbGeAlD
Iloperidone—HRH1—mammalian vulva—cervical cancer	0.00675	0.0159	CbGeAlD
Iloperidone—ADRA2A—mammalian vulva—cervical cancer	0.00663	0.0156	CbGeAlD
Iloperidone—HTR2A—epithelium—cervical cancer	0.0065	0.0153	CbGeAlD
Iloperidone—ADRA2C—female gonad—cervical cancer	0.00647	0.0152	CbGeAlD
Iloperidone—ADRA2C—vagina—cervical cancer	0.00643	0.0151	CbGeAlD
Iloperidone—ADRA2A—uterus—cervical cancer	0.00631	0.0149	CbGeAlD
Iloperidone—HTR2A—renal system—cervical cancer	0.00603	0.0142	CbGeAlD
Iloperidone—HRH1—female reproductive system—cervical cancer	0.00578	0.0136	CbGeAlD
Iloperidone—ADRA2A—female reproductive system—cervical cancer	0.00568	0.0134	CbGeAlD
Iloperidone—CYP3A4—renal system—cervical cancer	0.00558	0.0131	CbGeAlD
Iloperidone—CYP2E1—female reproductive system—cervical cancer	0.00555	0.0131	CbGeAlD
Iloperidone—CYP2D6—renal system—cervical cancer	0.00549	0.0129	CbGeAlD
Iloperidone—CYP3A5—female gonad—cervical cancer	0.00542	0.0127	CbGeAlD
Iloperidone—CYP3A5—vagina—cervical cancer	0.00538	0.0127	CbGeAlD
Iloperidone—SIGMAR1—lymph node—cervical cancer	0.0053	0.0125	CbGeAlD
Iloperidone—HRH1—female gonad—cervical cancer	0.00526	0.0124	CbGeAlD
Iloperidone—HRH1—vagina—cervical cancer	0.00523	0.0123	CbGeAlD
Iloperidone—ADRA2A—female gonad—cervical cancer	0.00517	0.0122	CbGeAlD
Iloperidone—ADRA2A—vagina—cervical cancer	0.00513	0.0121	CbGeAlD
Iloperidone—HTR2A—female reproductive system—cervical cancer	0.00483	0.0114	CbGeAlD
Iloperidone—CYP3A4—female reproductive system—cervical cancer	0.00447	0.0105	CbGeAlD
Iloperidone—CYP2D6—female reproductive system—cervical cancer	0.0044	0.0103	CbGeAlD
Iloperidone—HTR2A—vagina—cervical cancer	0.00437	0.0103	CbGeAlD
Iloperidone—ADRA2C—lymph node—cervical cancer	0.00416	0.00979	CbGeAlD
Iloperidone—CYP2D6—female gonad—cervical cancer	0.004	0.00941	CbGeAlD
Iloperidone—HRH1—lymph node—cervical cancer	0.00338	0.00795	CbGeAlD
Iloperidone—ADRA2A—lymph node—cervical cancer	0.00332	0.00781	CbGeAlD
Iloperidone—HTR1A—Signaling Pathways—TAAR6—cervical cancer	0.000536	0.000977	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—WNT5A—cervical cancer	0.000534	0.000974	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—TAAR6—cervical cancer	0.000534	0.000972	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—AKAP13—cervical cancer	0.000526	0.000959	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—WNT5A—cervical cancer	0.00052	0.000947	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—TAAR6—cervical cancer	0.000519	0.000946	CbGpPWpGaD
Iloperidone—HTR7—Circadian rythm related genes—TP53—cervical cancer	0.000508	0.000925	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—AKAP13—cervical cancer	0.000497	0.000905	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—AKAP13—cervical cancer	0.000496	0.000904	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—AKAP13—cervical cancer	0.000493	0.000898	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—AKAP13—cervical cancer	0.000489	0.000891	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—WNT2—cervical cancer	0.000487	0.000887	CbGpPWpGaD
Iloperidone—DRD4—Circadian rythm related genes—TP53—cervical cancer	0.000486	0.000885	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—WNT2—cervical cancer	0.00048	0.000875	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—AKAP13—cervical cancer	0.000475	0.000865	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—WNT5A—cervical cancer	0.000472	0.000859	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—CA9—cervical cancer	0.000471	0.000858	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—TAAR6—cervical cancer	0.000471	0.000858	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—WNT5A—cervical cancer	0.000464	0.000845	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—TAAR6—cervical cancer	0.000463	0.000844	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—WNT5A—cervical cancer	0.000463	0.000844	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—TAAR6—cervical cancer	0.000462	0.000842	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—CA9—cervical cancer	0.000458	0.000834	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—WNT5A—cervical cancer	0.000454	0.000828	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—TAAR6—cervical cancer	0.000454	0.000827	CbGpPWpGaD
Iloperidone—DRD1—Circadian rythm related genes—TP53—cervical cancer	0.000437	0.000797	CbGpPWpGaD
Iloperidone—DRD3—Circadian rythm related genes—TP53—cervical cancer	0.000432	0.000786	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—WNT5A—cervical cancer	0.000429	0.000781	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—WNT5A—cervical cancer	0.000428	0.00078	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—AKAP13—cervical cancer	0.000428	0.000779	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—WNT5A—cervical cancer	0.000425	0.000775	CbGpPWpGaD
Iloperidone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000422	0.000769	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—WNT5A—cervical cancer	0.000422	0.000769	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—AKAP13—cervical cancer	0.000422	0.000768	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—TAAR6—cervical cancer	0.000422	0.000768	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—WNT2—cervical cancer	0.000419	0.000763	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—WNT2—cervical cancer	0.000417	0.000759	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—WNT5A—cervical cancer	0.00041	0.000747	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—WNT2—cervical cancer	0.000405	0.000738	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—CA9—cervical cancer	0.000372	0.000677	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—WNT5A—cervical cancer	0.000369	0.000672	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—WNT2—cervical cancer	0.000368	0.00067	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—AKAP13—cervical cancer	0.000368	0.00067	CbGpPWpGaD
Iloperidone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000367	0.000668	CbGpPWpGaD
Iloperidone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000366	0.000667	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—AKAP13—cervical cancer	0.000366	0.000666	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—WNT5A—cervical cancer	0.000364	0.000663	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—WNT2—cervical cancer	0.000362	0.000659	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—WNT2—cervical cancer	0.000361	0.000658	CbGpPWpGaD
Iloperidone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000359	0.000654	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—AKAP13—cervical cancer	0.000356	0.000648	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—WNT2—cervical cancer	0.000354	0.000645	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—CA9—cervical cancer	0.000341	0.000622	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—CA9—cervical cancer	0.000341	0.000621	CbGpPWpGaD
Iloperidone—DRD2—Circadian rythm related genes—TP53—cervical cancer	0.00033	0.000602	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—WNT2—cervical cancer	0.000329	0.0006	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—AKAP13—cervical cancer	0.000323	0.000588	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—AKAP13—cervical cancer	0.000318	0.000579	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—WNT5A—cervical cancer	0.000317	0.000578	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—AKAP13—cervical cancer	0.000317	0.000577	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—WNT5A—cervical cancer	0.000316	0.000575	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—AKAP13—cervical cancer	0.000311	0.000567	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—WNT5A—cervical cancer	0.000307	0.000559	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—NOTCH2—cervical cancer	0.000301	0.000548	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—NOTCH2—cervical cancer	0.000301	0.000548	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—NOTCH2—cervical cancer	0.000299	0.000544	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—AKAP13—cervical cancer	0.000289	0.000526	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—NOTCH2—cervical cancer	0.000288	0.000524	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—WNT5A—cervical cancer	0.000279	0.000508	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—WNT5A—cervical cancer	0.000274	0.000499	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—WNT5A—cervical cancer	0.000274	0.000498	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—WNT5A—cervical cancer	0.000268	0.000489	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—NOTCH2—cervical cancer	0.000259	0.000472	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—NOTCH2—cervical cancer	0.000256	0.000466	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—WNT5A—cervical cancer	0.000249	0.000454	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—HES1—cervical cancer	0.000247	0.000449	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—HES1—cervical cancer	0.000246	0.000449	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—HES1—cervical cancer	0.000245	0.000446	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—CA9—cervical cancer	0.000242	0.000441	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—HES1—cervical cancer	0.000236	0.00043	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—NOTCH2—cervical cancer	0.000223	0.000406	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—NOTCH2—cervical cancer	0.000222	0.000404	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—TERT—cervical cancer	0.000216	0.000394	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—TERT—cervical cancer	0.000216	0.000393	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—NOTCH2—cervical cancer	0.000216	0.000393	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—TERT—cervical cancer	0.000215	0.000391	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—HES1—cervical cancer	0.000212	0.000387	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—HES1—cervical cancer	0.00021	0.000382	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—TERT—cervical cancer	0.000207	0.000377	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—CA9—cervical cancer	0.000205	0.000374	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—FGFR3—cervical cancer	0.000198	0.000361	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—FGFR3—cervical cancer	0.000198	0.000361	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—FGFR3—cervical cancer	0.000197	0.000359	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—NOTCH2—cervical cancer	0.000196	0.000356	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—NOTCH2—cervical cancer	0.000192	0.000351	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—NOTCH2—cervical cancer	0.000192	0.00035	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—MTHFR—cervical cancer	0.000191	0.000348	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—FGFR3—cervical cancer	0.00019	0.000346	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—NOTCH2—cervical cancer	0.000188	0.000343	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—NOTCH1—cervical cancer	0.000186	0.000339	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—TERT—cervical cancer	0.000186	0.000339	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—NOTCH1—cervical cancer	0.000186	0.000339	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—MTHFR—cervical cancer	0.000186	0.000338	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—NOTCH1—cervical cancer	0.000185	0.000337	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—TERT—cervical cancer	0.000184	0.000334	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—HES1—cervical cancer	0.000183	0.000333	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—HES1—cervical cancer	0.000182	0.000331	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—NOTCH1—cervical cancer	0.000178	0.000324	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—HES1—cervical cancer	0.000177	0.000322	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—NOTCH2—cervical cancer	0.000175	0.000319	CbGpPWpGaD
Iloperidone—ADRA2C—Hemostasis—TP53—cervical cancer	0.000174	0.000317	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—FGFR3—cervical cancer	0.000171	0.000311	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—FGFR3—cervical cancer	0.000169	0.000307	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—EGFR—cervical cancer	0.000166	0.000302	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—EGFR—cervical cancer	0.000166	0.000302	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—EGFR—cervical cancer	0.000165	0.0003	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—HES1—cervical cancer	0.00016	0.000292	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—NOTCH1—cervical cancer	0.00016	0.000292	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—TERT—cervical cancer	0.00016	0.000292	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—TERT—cervical cancer	0.000159	0.00029	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—EGFR—cervical cancer	0.000159	0.000289	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CA9—cervical cancer	0.000158	0.000288	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—NOTCH1—cervical cancer	0.000158	0.000288	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—HES1—cervical cancer	0.000158	0.000287	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—HES1—cervical cancer	0.000157	0.000287	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—TERT—cervical cancer	0.000155	0.000282	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—HES1—cervical cancer	0.000154	0.000281	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—MTHFR—cervical cancer	0.000151	0.000275	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—FGFR3—cervical cancer	0.000147	0.000268	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—FGFR3—cervical cancer	0.000146	0.000266	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—HES1—cervical cancer	0.000144	0.000261	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—EGFR—cervical cancer	0.000143	0.00026	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—FGFR3—cervical cancer	0.000142	0.000259	CbGpPWpGaD
Iloperidone—ADRA2A—Hemostasis—TP53—cervical cancer	0.000141	0.000257	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—EGFR—cervical cancer	0.000141	0.000257	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—TERT—cervical cancer	0.000141	0.000256	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—MTOR—cervical cancer	0.00014	0.000254	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—MTOR—cervical cancer	0.000139	0.000254	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—MTHFR—cervical cancer	0.000139	0.000252	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—MTOR—cervical cancer	0.000139	0.000252	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—TERT—cervical cancer	0.000138	0.000252	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—MTHFR—cervical cancer	0.000138	0.000252	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—TERT—cervical cancer	0.000138	0.000251	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—NOTCH1—cervical cancer	0.000138	0.000251	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—NOTCH1—cervical cancer	0.000137	0.00025	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—TERT—cervical cancer	0.000135	0.000247	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—MTOR—cervical cancer	0.000133	0.000243	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—NOTCH1—cervical cancer	0.000133	0.000243	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—FGFR3—cervical cancer	0.000129	0.000235	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—CASP3—cervical cancer	0.000128	0.000234	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—CASP3—cervical cancer	0.000128	0.000234	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—CASP3—cervical cancer	0.000127	0.000232	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—FGFR3—cervical cancer	0.000127	0.000231	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—FGFR3—cervical cancer	0.000127	0.000231	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—TERT—cervical cancer	0.000126	0.000229	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—FGFR3—cervical cancer	0.000124	0.000226	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—CTNNB1—cervical cancer	0.000124	0.000225	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—CTNNB1—cervical cancer	0.000124	0.000225	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—EGFR—cervical cancer	0.000123	0.000224	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—CTNNB1—cervical cancer	0.000123	0.000224	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—CASP3—cervical cancer	0.000123	0.000224	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—EGFR—cervical cancer	0.000122	0.000223	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—NOTCH1—cervical cancer	0.000121	0.000221	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—MTOR—cervical cancer	0.00012	0.000219	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—NOTCH1—cervical cancer	0.000119	0.000217	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—EGFR—cervical cancer	0.000119	0.000217	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—NOTCH1—cervical cancer	0.000119	0.000217	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—MTOR—cervical cancer	0.000119	0.000216	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—CTNNB1—cervical cancer	0.000118	0.000216	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—NOTCH1—cervical cancer	0.000117	0.000212	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—FGFR3—cervical cancer	0.000115	0.00021	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—CASP3—cervical cancer	0.000111	0.000201	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—CASP3—cervical cancer	0.000109	0.000199	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—NOTCH1—cervical cancer	0.000108	0.000197	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—STAT3—cervical cancer	0.000108	0.000196	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—EGFR—cervical cancer	0.000108	0.000196	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—STAT3—cervical cancer	0.000108	0.000196	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—STAT3—cervical cancer	0.000107	0.000195	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—CTNNB1—cervical cancer	0.000107	0.000194	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—EGFR—cervical cancer	0.000106	0.000193	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—EGFR—cervical cancer	0.000106	0.000193	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—CTNNB1—cervical cancer	0.000105	0.000191	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—EGFR—cervical cancer	0.000104	0.000189	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—MTOR—cervical cancer	0.000103	0.000188	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—STAT3—cervical cancer	0.000103	0.000188	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—MTOR—cervical cancer	0.000103	0.000187	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—MTOR—cervical cancer	0.0001	0.000182	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—MTHFR—cervical cancer	9.83e-05	0.000179	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—EGFR—cervical cancer	9.8e-05	0.000179	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—EGFR—cervical cancer	9.79e-05	0.000178	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—EGFR—cervical cancer	9.73e-05	0.000177	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—EGFR—cervical cancer	9.65e-05	0.000176	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CASP3—cervical cancer	9.5e-05	0.000173	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CASP3—cervical cancer	9.45e-05	0.000172	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—EGFR—cervical cancer	9.37e-05	0.000171	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—STAT3—cervical cancer	9.28e-05	0.000169	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CASP3—cervical cancer	9.2e-05	0.000168	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—STAT3—cervical cancer	9.16e-05	0.000167	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CTNNB1—cervical cancer	9.16e-05	0.000167	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CTNNB1—cervical cancer	9.11e-05	0.000166	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—MTOR—cervical cancer	9.07e-05	0.000165	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—MTOR—cervical cancer	8.93e-05	0.000163	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—MTOR—cervical cancer	8.91e-05	0.000162	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CTNNB1—cervical cancer	8.86e-05	0.000161	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—MTOR—cervical cancer	8.74e-05	0.000159	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—EGFR—cervical cancer	8.44e-05	0.000154	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CASP3—cervical cancer	8.34e-05	0.000152	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—MTHFR—cervical cancer	8.33e-05	0.000152	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—EGFR—cervical cancer	8.33e-05	0.000152	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—TP53—cervical cancer	8.23e-05	0.00015	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—TP53—cervical cancer	8.22e-05	0.00015	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CASP3—cervical cancer	8.21e-05	0.00015	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CASP3—cervical cancer	8.19e-05	0.000149	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—TP53—cervical cancer	8.17e-05	0.000149	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—MTOR—cervical cancer	8.12e-05	0.000148	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CTNNB1—cervical cancer	8.04e-05	0.000147	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CASP3—cervical cancer	8.04e-05	0.000146	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—STAT3—cervical cancer	7.98e-05	0.000145	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—STAT3—cervical cancer	7.94e-05	0.000145	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CTNNB1—cervical cancer	7.91e-05	0.000144	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CTNNB1—cervical cancer	7.9e-05	0.000144	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—TP53—cervical cancer	7.87e-05	0.000143	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CTNNB1—cervical cancer	7.75e-05	0.000141	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—STAT3—cervical cancer	7.73e-05	0.000141	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CASP3—cervical cancer	7.47e-05	0.000136	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—EGFR—cervical cancer	7.26e-05	0.000132	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—EGFR—cervical cancer	7.22e-05	0.000132	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CTNNB1—cervical cancer	7.2e-05	0.000131	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—TP53—cervical cancer	7.09e-05	0.000129	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—EGFR—cervical cancer	7.02e-05	0.000128	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—STAT3—cervical cancer	7.01e-05	0.000128	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—TP53—cervical cancer	6.99e-05	0.000127	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—STAT3—cervical cancer	6.9e-05	0.000126	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—STAT3—cervical cancer	6.88e-05	0.000125	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—STAT3—cervical cancer	6.75e-05	0.000123	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—MTHFR—cervical cancer	6.43e-05	0.000117	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—EGFR—cervical cancer	6.37e-05	0.000116	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—STAT3—cervical cancer	6.28e-05	0.000114	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—EGFR—cervical cancer	6.27e-05	0.000114	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—EGFR—cervical cancer	6.26e-05	0.000114	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—EGFR—cervical cancer	6.14e-05	0.000112	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—TP53—cervical cancer	6.09e-05	0.000111	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—TP53—cervical cancer	6.06e-05	0.00011	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—TP53—cervical cancer	5.9e-05	0.000107	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—EGFR—cervical cancer	5.7e-05	0.000104	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—TP53—cervical cancer	5.35e-05	9.75e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—TP53—cervical cancer	5.26e-05	9.59e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—TP53—cervical cancer	5.25e-05	9.57e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—TP53—cervical cancer	5.15e-05	9.39e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—TP53—cervical cancer	4.79e-05	8.72e-05	CbGpPWpGaD
